1. Chun-Sung Sung, Tzu-Jung Wei, Jung-Jyh Hung, Fu-Wei Su, Shih-I Ho, Mong-Wei Lin, Kuang-Cheng Chan, Chun-Yu Wu. Comparisons in analgesic effects between ultrasound- guided erector spinae plane block and surgical intercostal nerve block after video- assisted thoracoscopic surgery: A randomized controlled trial. J Clin Anesth. 2024 Aug;95:111448.
2. Tseng YH, Pan SW, Huang JR, Lee CC, Hung JJ, Hsu PK, Chen NJ, Su WJ, Chen YM, Feng JY. Promoter methylation and increased expression of PD-L1 in patients with active tuberculosis. Microb Cell. 2024 Jul 29;11:278.
3. Hung JJ,* Kao YS, Huang CH, et al. Overexpression of Aiolos promotes epithelial- mesenchymal transition and cancer stem cell-like properties in lung cancer cells. Sci Rep 2019;9:2991. (SCI, IF: 3.998) (*Corresponding author)
4. Lin YH, Hung JJ,* Yeh YC, et al. Prognostic significance of basal versus superior segment in patients with completely resected lung adenocarcinoma in the lower lobe. Thorac Cancer 2019;10:312-320. (SCI, IF: 2.610) (*Corresponding author)
5. Hung JJ,* Yeh YC, Hsu WH. Prognostic significance of aldo-keto reductase family 1 member B10 in patients with resected lung adenocarcinoma. Thorac Cancer 2018;9:1492-1499. (SCI, IF: 2.610) (*Corresponding author)
6. Hung JJ,* Yeh YC, Wu YC, et al. Prognostic Factors in Completely Resected Node- negative Lung Adenocarcinoma of 3cm or Smaller. J Thorac Oncol 2017;12:1824- 1833. (SCI, IF: 13.357) (*Corresponding author)
7. Hung JJ, Wu YC, Chou TY, et al. Adjuvant Chemotherapy Improves the Probability of Freedom from Recurrence in Patients with Resected Stage IB Lung Adenocarcinoma. Ann Thorac Surg 2016;101:1346-1353. (SCI, IF: 3.639)
8. Hung JJ,* Yeh YC, Jeng WJ, et al. Factors predicting occult lymph node metastasis in completely resected lung adenocarcinoma of 3cm or smaller. Eur J Cardiothorac Surg 2016;50:329-336. (SCI, IF 3.486) (*Corresponding author)
9. Hung JJ,* Yeh YC, Jeng WJ, et al. Prognostic Factors of Survival after Recurrence in Patients with Resected Lung Adenocarcinoma. J Thorac Oncol 2015;10:1328-1336. (SCI, IF: 13.357) (*Corresponding author)
10. Hung JJ, Yeh YC, Jeng WJ, et al. Predictive Value of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma in Tumor Recurrence and Patient Survival. J Clin Oncol 2014;32:2357-2364. (SCI, IF: 32.956)
11. Hung JJ,* Jeng WJ, Chou TY, et al. Prognostic Value of the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Lung Adenocarcinoma Classification on Death and Recurrence in Completely Resected Stage I Lung Adenocarcinoma. Ann Surg 2013;258:1079-86. (SCI, IF: 10.130) (*Corresponding author)
12. Liu CY, Hung JJ,* Wang BY, et al. Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer. Eur Respir J 2013;41:649-55. (SCI, IF: 12.339) (*Co-first author)
13. Hung JJ,* Jeng WJ, Hsu WH, et al. Prognostic Significance of the Extent of Visceral Pleural Invasion in Completely Resected Node-Negative Non-small Cell Lung Cancer. Chest 2012;142:141-50. (SCI, IF: 8.308) (*Corresponding author)
14. Hung JJ,* Jeng WJ, Hsu WH, et al. Time Trends of Overall Survival and Survival after Recurrence in Completely Resected Stage I Non-small Cell Lung Cancer. J Thorac Oncol 2012;7:397-405. (SCI, IF: 13.357) (*Corresponding author)
15. Hung JJ, Jeng WJ, Hsu WH, et al. Predictors of Death, Local Recurrence, and Distant Metastasis in Completely Resected Pathological Stage-I Non-Small-Cell Lung Cancer. J Thorac Oncol 2012;7:1115-23. (SCI, IF: 13.357)
16. Hung JJ,* Jeng WJ, Hsu WH, et al. Prognostic factors of post-recurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis. Thorax 2010;65:241-5. (SCI, IF: 8.834) (*Corresponding author)
17. Hung JJ, Jeng WJ, Hsu WH, et al. Prognostic factors in pathological stage IB non-small cell lung cancer greater than 3 cm. Eur Respir J 2010;36:1355-61. (SCI, IF: 12.339)
18. Hung JJ, Hsu WH, Hsieh CC, et al. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence. Thorax 2009;64:192-6. (SCI, IF: 8.834)
19. Hung JJ, Yang MH, Hsu HS, et al. Prognostic significance of hypoxia-inducible factor-1a, TWIST1 and Snail expression in resectable non-small cell lung cancer. Thorax 2009;64:1082-9. (SCI, IF: 8.834)
20. Hung JJ, Wang CY, Huang MH, et al. Prognostic Factors in Resected Stage I Non-small Cell Lung Cancer of Diameter 3 cm or Less: Visceral pleural invasion did not influence overall and disease-free survival. J Thorac Cardiovasc Surg 2007;134:638-43. (SCI, IF: 4.451)